Dr David Bell:
"One of the core principles of medical research is that a clinical trial must seek to answer a question that cannot be resolved by other means. Yet in the case of puberty blockers, safer research avenues remain unexplored. We should be conducting robust long-term follow-up studies of those who have already undergone such treatment, qualitative research into the experiences of the growing numbers of detransitioners, and further animal studies to understand the biological impact of these drugs on adolescent brain development."
Link to 35 minute podcast in the article.
This man deserves the highest honours available.
telegraph.co.uk/gift/03d6f36941854567